The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study

Study (n=281) found a reduction in microbiome diversity, particularly one with dominance of Pseudomonas, is associated with greater disease severity and a higher risk of mortality. Microbiome might help identify patients who could benefit from precision treatment strategies.

Source:

The Lancet Respiratory Medicine